No Data
No Data
UNITED LAB To Go Ex-Dividend On June 17th, 2024 With 0.30872 HKD Dividend Per Share And 0.13231 HKD Special Dividend Per Share
March 27th - $UNITED LAB(03933.HK)$ is trading ex-dividend on June 17th, 2024. Shareholders of record on June 18th, 2024 will receive 0.30872 HKD dividend per share and 0.13231 HKD special dividen
The United Laboratories International's 2023 Profit Rises on Higher Revenue
The United Laboratories International Holdings' (HKG:3933) attributable profit increased to 2.70 billion yuan, or 1.4867 yuan per share, in 2023, from 1.58 billion yuan, or 0.8689 yuan per share, in 2
[Hong Kong Stock Connect] Federal Pharmaceuticals (03933) increased profit by 70.9% last year to RMB 2,701 billion and distributed a total of 40 points with a special dividend
Jinwu Financial News | Federal Pharmaceuticals (03933) announced that in 2023, company owners should account for the current year's profit of RMB 2,701 billion (RMB, same below), up 70.9% year on year; basic profit per share was 148.67 points, up 71.1% year on year; the board of directors proposed to pay a final dividend of RMB 28 points per share for the year ended December 31, 2023, and a special dividend of RMB 12 points per share. Together with the interim dividend of RMB 12 per share already paid, the annual dividend is RMB 52 cents per share. During the period, the company achieved revenue of 13.74 billion yuan, an increase of 21.2 billion yuan over the previous year
Federal Pharmaceuticals (03933.HK): Net profit increased 70.9% to 2.701 billion yuan in 2023, R&D investment increased 36.2% year-on-year
On March 27, Gelonghui (03933.HK) announced its 2023 annual results announcement. During the year under review, the Group recorded a turnover of approximately RMB 13.794 billion, an increase of about 21.2% over 2022. Profit attributable to company owners was RMB 2,701 billion, an increase of 70.9% over the previous year. Earnings per share were RMB 148.67 cents. The Board recommended a final dividend of RMB 28 points per share and a special dividend of RMB 12 points per share. Together with the interim dividend of RMB 12 per share already paid, the annual dividend is RMB 52 cents per share. GLP-1 Pharmacopoeia
Federal Pharmaceuticals (03933) announced annual results. Profit attributable to shareholders was 2.701 billion yuan, an increase of 70.9% over the previous year, with proposed final interest of 28 points per share and special interest of 12 points per sh
Federal Pharmaceuticals (03933) announced its 2023 annual results announcement, with revenue of about 13.74 billion yuan (RMB, below...
UNITED LAB: 2023 ANNUAL RESULTS ANNOUNCEMENT
No Data